KCI Lobbies Congress Over Next Round Of Medicare Competitive Bidding
This article was originally published in The Gray Sheet
Executive SummaryExecutives at device maker KCI want Washington policy-makers to consider the potential safety and cost impacts of including negative pressure wound therapy products in the next round of Medicare's competitive bidding program.
You may also be interested in...
The drive toward cost-effectiveness and expanded patient access have spurred device developers to take proven therapies or procedures and re-engineer them in ways that make them simpler, less expensive and easier to use. Now, the biggest player in wound care is following suit. In January, Smith & Nephew PLC announced that the FDA had cleared PICO, its new, single-use, pocket-sized negative pressure wound therapy (NPWT) system.
News from the Medicare agency includes updates on the DME competitive bidding program, overpayment recoveries and obesity screening.